SEC Form 4 · accession 0001140361-17-002310
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Hollingshead
Officer — President, Americas
Period of report
Jan 17, 2017
Accepted (ET)
Jan 19, 2017 · 5:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Jan 17, 2017 | M | 5,264 | $43.63 | A | 46,754 | D | |
| ResMed Common Stock | Jan 17, 2017 | S | 5,264 | $64.44 | D | 41,490 | D | |
| ResMed Common Stock | Jan 17, 2017 | S | 1,820 | $64.44 | D | 39,670 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF2 | $43.63 | Jan 17, 2017 | M | 5,264 | D | Mar 1, 2014 | Mar 1, 2020 | ResMed Common Stock | 5,264 | 17,548 | D |
Explanation of responses
- F1The transaction was conducted under a Rule 10b5-1 Plan.
- F2Represents date options first became exercisable. Options vest ? per year.